These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28414858)

  • 21. Unusual primary cutaneous amyloidosis with an incontinentia pigmenti-like pattern.
    Wan H; Ran Y
    Int J Dermatol; 2011 Apr; 50(4):485-7. PubMed ID: 21413964
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cerebral white matter lesions in a case of incontinentia pigmenti with infantile spasms, mental retardation and left hemiparesis].
    Sasaki M; Hanaoka S; Suzuki H; Takashima S; Arima M
    No To Hattatsu; 1991 May; 23(3):278-83. PubMed ID: 2043371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incontinentia Pigmenti with vesicular stage in utero.
    Osório F; Magina S; Nogueira A; Azevedo F
    Dermatol Online J; 2010 Oct; 16(10):13. PubMed ID: 21062607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incontinentia pigmenti: a rare cause of retinal vasculitis in children.
    El Fekih L; Hmaied W; Souissi K; Nasri H; Derbel F; Hamdi A
    Tunis Med; 2008 Dec; 86(12):1079-81. PubMed ID: 19213518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticosteroid Therapy in Neonatal Incontinentia Pigmenti With Asymptomatic Cerebral Lesions.
    Ogasawara K; Honda Y; Maeda H; Sato M; Nakano H; Hosoya M
    Pediatr Neurol; 2019 Oct; 99():85-87. PubMed ID: 31201074
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapeutic use of topical corticosteroids in the vesiculobullous lesions of incontinentia pigmenti.
    Kaya TI; Tursen U; Ikizoglu G
    Clin Exp Dermatol; 2009 Dec; 34(8):e611-3. PubMed ID: 19489863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intralesional methotrexate for keratoacanthoma of the nose.
    Cohen PR; Schulze KE; Teller CF; Nelson BR
    Skinmed; 2005; 4(6):393-5. PubMed ID: 16276163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple keratoacanthomas in a young woman: report of a case emphasizing medical management and a review of the spectrum of multiple keratoacanthomas.
    Feldman RJ; Maize JC
    Int J Dermatol; 2007 Jan; 46(1):77-9. PubMed ID: 17214727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incontinentia pigmenti with painful subungual tumors: a two-generation study.
    Montes CM; Maize JC; Guerry-Force ML
    J Am Acad Dermatol; 2004 Feb; 50(2 Suppl):S45-52. PubMed ID: 14726866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incontinentia pigmenti (Bloch-Sulzberger syndrome) manifesting as painful periungual and subungual tumours.
    Adeniran A; Townsend PL; Peachey RD
    J Hand Surg Br; 1993 Oct; 18(5):667-9. PubMed ID: 8294840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal white matter in a neurologically intact child with incontinentia pigmenti.
    Bryant SA; Rutledge SL
    Pediatr Neurol; 2007 Mar; 36(3):199-201. PubMed ID: 17352958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of Corticosteroid Therapy for Acute Neurological Symptoms in Incontinentia Pigmenti.
    Tomotaki S; Shibasaki J; Yunoki Y; Kishigami M; Imagawa T; Aida N; Toyoshima K; Itani Y
    Pediatr Neurol; 2016 Mar; 56():55-58. PubMed ID: 26777982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial subungual keratoacanthoma in association with ectodermal dysplasia.
    Shatkin BT; Hunter JG; Song IC
    Plast Reconstr Surg; 1993 Sep; 92(3):528-31. PubMed ID: 8341755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incontinentia pigmenti.
    Motamedi MH; Lotfi A; Azizi T; Moshref M; Farhadi S
    Indian J Pathol Microbiol; 2010; 53(2):302-4. PubMed ID: 20551538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Keratoacanthoma en plaque/nodule: A brief report of the clinicopathological features of five cases.
    Misago N; Ansai SI; Fukumoto T; Anan T; Nakao T
    J Dermatol; 2017 Jul; 44(7):803-807. PubMed ID: 28332728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incontinentia pigmenti.
    Poziomczyk CS; Recuero JK; Bringhenti L; Maria FD; Campos CW; Travi GM; Freitas AM; Maahs MA; Zen PR; Fiegenbaum M; Almeida ST; Bonamigo RR; Bau AE
    An Bras Dermatol; 2014; 89(1):26-36. PubMed ID: 24626645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incontinentia pigmenti with encephalocele in a neonate: a rare association.
    Demirel N; Aydin M; Zenciroglu A; Okumus N; Tekgunduz KS; Ipek MS; Boduroglu E
    J Child Neurol; 2009 Apr; 24(4):495-9. PubMed ID: 19339289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extensive vesiculobullous eruption following limited ruby laser treatment for incontinentia pigmenti: a case report.
    Nagase T; Takanashi M; Takada H; Ohmori K
    Australas J Dermatol; 1997 Aug; 38(3):155-7. PubMed ID: 9293665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and histologic features of incontinentia pigmenti in adults with nuclear factor-κB essential modulator gene mutations.
    Hadj-Rabia S; Rimella A; Smahi A; Fraitag S; Hamel-Teillac D; Bonnefont JP; de Prost Y; Bodemer C
    J Am Acad Dermatol; 2011 Mar; 64(3):508-15. PubMed ID: 21255870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incontinentia pigmenti (Bloch-Sulzberger syndrome): a case report and review of the ocular pathological features.
    Heathcote JG; Schoales BA; Willis NR
    Can J Ophthalmol; 1991 Jun; 26(4):229-37. PubMed ID: 1889027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.